3.4-fold higher risk of
stroke and death in CAS compared with CEA.175 In contrast,
a recent study by AbuRahma et al403 of 409 patients who
underwent CAS between 2004 and 2015 found no signiﬁcant difference in stroke and major adverse events in
regards to the stent length, number of stents or stent
diameter after CAS.403 However